← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
ADCBiologicQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (QL1706)

TNBC, Triple Negative Breast Cancer · Recurrent Cervical Cancer

#RecurrentCervicalCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 60상태 RECRUITING
AntibodySun Yat-sen Universityvedotin combined with immun…Phase 3

Serplulimab (Serplulimab)

Colorectal Cancer; Liver Metastases · Solid Tumor Cancer

#SolidTumorCancer#Antibody#Phase3#인기#항체+5
임상시험 60상태 RECRUITING
CGTBiologicLion TCR Pte. Ltd.Phase 1

TCR-T (TCR-T)

Chronic Hepatitis B · Chronic Hepatitis B

#ChronicHepatitisB#CGT#Phase1#인기#세포유전치료+4
효능 ORR 50%임상시험 60상태 ACTIVE
AntibodyJanssenApproved

Teclistamab (Teclistamab)

Myeloma Multiple; Plasma Cell Leukemia · Myeloma Multiple

#MyelomaMultiple#Antibody#Approved#인기#항체+5
임상시험 60상태 RECRUITING
AntibodyRocheDM1) and trastuzumab deruxt…Preclinical

trastuzumab (Herceptin, Trastuzumab + Pertuzumab)

Solid Tumor; Advanced Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Preclinical#인기#항체+5
효능 ORR 79.5%임상시험 60상태 RECRUITING
CGTBiologicAbbottvedotinPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicSabz BiomedicalsPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Colon Cancer Stage IV · Solid Tumors

#SolidTumors#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 ACTIVE
ADCBiologicCanadian Cancer Trials Groupderuxtecan (T-DXd) showed a…Phase 2

darolutamide (darolutamide)

Prostate Cancer · Genitourinary Cancers

#GenitourinaryCancers#ADC#Phase2#인기#항체약물접합체+4
임상시험 60상태 RECRUITING
AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, ipilimumab + nivolumab)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#인기#항체+4
효능 ORR 77.8%임상시험 60상태 RECRUITING
ADCBiologicGruppo Oncologico del Nord-OvestPhase 3

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 36.6%임상시험 60상태 ACTIVE
CGTBiologicGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 13%임상시험 60상태 ACTIVE
CGTBiologicCelgenevedotin (BV) maintenance th…Phase 2

ASCT (ASCT)

Multiple Myeloma; Newly Diagnosed · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#인기#세포유전치료+5
효능 ORR 11%임상시험 59상태 RECRUITING
CGTBiologicAbClonvedotin-containing regimens…Phase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 38%임상시험 59상태 RECRUITING
ADCBiologicMing-Yuan ChenPhase 3

Adjuvant Cisplatin (Adjuvant Cisplatin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#인기#항체약물접합체+2
효능 ORR 40%임상시험 59상태 RECRUITING
ADCBiologicSWOG Cancer Research NetworksPhase 3

Afatinib Dimaleate (Afatinib Dimaleate)

Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicFondazione per la Medicina Pers…releasePhase 2

Alpelisib (Alpelisib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 43.3%임상시험 59상태 DISCONTINUED
ADCBiologicGenentech, Inc.Preclinical

Anti-angiogenic drug (Anti-angiogenic drug)

Gastric Cancer; Second-line Treatment · Gastric Cancer

#GastricCancer#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 96%임상시험 59상태 RECRUITING
AntibodyRegeneronDemonstratePhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#인기#항체+5
효능 ORR 100%임상시험 59상태 RECRUITING
AntibodyUCB PharmaApproved

Certolizumab (Certolizumab)

Psoriasis; Atopic Dermatitis · Chronic Nonbacterial Osteomyelitis

#ChronicNonbacterialOsteomyelitis#Antibody#Approved#인기#항체+5
효능 ORR 5%임상시험 59상태 RECRUITING
ADCBiologicKaryopharm Therapeutics IncPhase 2

Clarithromycin (Clarithromycin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 6%임상시험 59상태 RECRUITING

16 / 209 페이지

← 이전다음 →